Ryusuke Nishikawa

Low Body Weight and Long-Term Outcomes in Cancer-Associated Venous Thromboembolism ― From the COMMAND VTE Registry-2 ―

Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto et autres

BACKGROUND: Low body weight (BW) is reportedly associated with an increased risk of bleeding and mortality in venous thromboembolism (VTE). However, there are limited data on the impact of low BW on clinical outcomes among patients with cancer-associated VTE in the direct …

jp (code pays fourni par la source)

Midterm outcomes after TAVR or SAVR in low-risk patients with severe aortic stenosis in the real clinical practice in Japan

Kotaro Takahashi, Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto et autres

jp (code pays fourni par la source)

One-Month Outcomes of Aspirin-Free Strategy for Percutaneous Coronary Intervention With or Without Proton-Pump Inhibitors ― A Post Hoc Subgroup Analysis of STOPDAPT-3 ―

Ryota Nishio, Hirotoshi Watanabe, Takeshi Morimoto, M Natsuaki et autres

Background: There are no previous reports exploring the interaction of proton-pump inhibitors (PPI) on the early effect of aspirin-free strategy compared with dual antiplatelet therapy (DAPT) after PCI. Methods and Results: Among 5,654 patients who were discharged alive within 30 days after …

jp (code pays fourni par la source)

Stable, Progressive, and Acute Valve Syndrome in Severe Aortic Stenosis: Insights from the CURRENT AS Registry‐2.

Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, Shinichi Shirai et autres

BACKGROUND: A valve syndrome framework (stable valve syndrome [SVS], progressive valve syndrome [PVS], and acute valve syndrome [AVS]) integrates clinical presentation with objective markers, but its prognostic implications remain incompletely characterized. METHODS: Among 3369 consecutive patients with severe aortic stenosis (AS) in …

jp (code pays fourni par la source)

A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants

Tomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, Takeshi Morimoto et autres

BACKGROUND: Patients with cancer-associated venous thromboembolism (VTE) are at a high risk of major bleeding during anticoagulant therapy, emphasizing the need for bleeding risk assessment in the era of direct oral anticoagulants (DOACs). However, few bleeding risk scores have been specifically developed …

jp (code pays fourni par la source)

Cardiac damage stages at follow-up and subsequent clinical outcomes in patients with severe aortic stenosis

Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, Shinichi Shirai et autres

jp (code pays fourni par la source)

Aspirin versus clopidogrel beyond 1 month after percutaneous coronary intervention in high bleeding risk patients with or without acute coronary syndrome: a subgroup analysis from the STOPDAPT-3 trial

Tetsuya Ishikawa, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto et autres

jp (code pays fourni par la source)

Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, Ko Yamamoto et autres

BACKGROUND: Clopidogrel may have ischemic benefit over aspirin as long-term monotherapy in patients receiving percutaneous coronary intervention. METHODS: Both the STOPDAPT-2 (Short and Optimal Duration of Dual Antiplatelet Therapy-2) and STOPDAPT-2 ACS (Short and Optimal Duration of Dual Antiplatelet Therapy-2 Study for …

jp (code pays fourni par la source)

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―

Kenji Kanenawa, K Yamamoto, Takenori Domei, Masahiro Natsuaki et autres

BACKGROUND: inhibitor monotherapy following short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients with diabetes. METHODS AND RESULTS: =0.04). CONCLUSIONS: From 30 days to 1 year after PCI, cardiovascular outcomes were similar between aspirin and clopidogrel regardless of diabetes. …

jp (code pays fourni par la source)

Changes in Demographics, Initial Treatment Strategies, and Clinical Outcomes of Severe Aortic Stenosis in the Pre- and Post-TAVR Era in Japan

Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, Shinichi Shirai et autres

BACKGROUND: The overall impact of the introduction of transcatheter aortic valve replacement (AVR) on the prognosis of the entire population with severe aortic stenosis has not been evaluated. METHODS: We analyzed 2 multicenter registries that consecutively enrolled patients with severe aortic stenosis …

jp (code pays fourni par la source)

Real-world management and outcomes of venous thromboembolism in patients with cancer and limited life expectancy in the direct oral anticoagulant era: insights from the COMMAND VTE Registry-2

Takahiro Kuno, Norimichi Koitabashi, Yugo Yamashita, Takeshi Morimoto et autres

BACKGROUND: Optimal management strategies for venous thromboembolism (VTE) in patients with cancer and limited life expectancy (LLE) could still be challenging in the current era of widespread use of direct oral anticoagulants (DOACs). Real-world treatment patterns and outcomes in patients with LLE …

jp (code pays fourni par la source)

Low-flow and normal-flow low-gradient aortic stenosis with reduced left ventricular ejection fraction. Insights from the CURRENT AS Registry-2

Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, Shinichi Shirai et autres

jp (code pays fourni par la source)